iCoreConnect Announces Reseller Agreement With mConsent To Integrate iCoreRx ePrescribing Software Into Patient Engagement Platform; Partnership Enhances mConsent's Digital Solutions For Dental Practices With Advanced Prescription Workflow And Patient Safety Features
Portfolio Pulse from Benzinga Newsdesk
iCoreConnect has announced a reseller agreement with mConsent to integrate its iCoreRx ePrescribing software into mConsent's patient engagement platform. This partnership aims to enhance mConsent's digital solutions for dental practices by providing advanced prescription workflow and patient safety features.
August 05, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
iCoreConnect has entered into a reseller agreement with mConsent to integrate its iCoreRx ePrescribing software into mConsent's patient engagement platform. This partnership is expected to enhance mConsent's digital solutions for dental practices, providing advanced prescription workflow and patient safety features.
The partnership with mConsent is likely to expand the market reach of iCoreConnect's iCoreRx ePrescribing software, potentially increasing its customer base and revenue. The integration of advanced prescription workflow and patient safety features into mConsent's platform could make iCoreConnect's offerings more attractive to dental practices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100